[{"Assets_0_Q2_USD":83485000.0,"EarningsPerShareBasic_1_Q2_USD":-0.16,"EarningsPerShareBasic_2_Q2_USD":-0.34,"EarningsPerShareDiluted_1_Q2_USD":-0.16,"EarningsPerShareDiluted_2_Q2_USD":-0.34,"NetIncomeLoss_1_Q2_USD":-17083000.0,"NetIncomeLoss_2_Q2_USD":-35681000.0,"StockholdersEquity_0_Q2_USD":39291000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":105044000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":104308000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":105044000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":104308000.0,"Ticker":"CERS","CIK":"1020214","name":"CERUS CORP","OfficialName":"Cerus Corporation Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"830388885.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170804"}]